Yahoo Web Search

Search results

1. • SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of...

     WMBD - FOX 43 Peoria· 2 days ago

     Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and reminds investors ...

2. • 

     AbbVie Stock Falls As Company Warns of Continued Humira Sales Slump

     Investopedia· 2 days ago

     Shares of AbbVie (ABBV) slumped Friday as the pharmaceutical firm warned of deeper declines in sales...

3. • Reviva Pharmaceuticals (NASDAQ:RVPH) vs. Bristol-Myers Squibb (NYSE:BMY) Head to Head Survey

     ETF DAILY NEWS· 3 days ago

     Bristol-Myers Squibb (NYSE:BMY – Get Free Report) and Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report) are both medical companies, but which is the better investment? We will compare the ...

4. • Option Care Health (OPCH) to Release Earnings on Tuesday

     ETF DAILY NEWS· 7 days ago

     Option Care Health (NASDAQ:OPCH – Get Free Report) will post its quarterly earnings results before the market opens on Tuesday, April 23rd. Analysts expect Option Care Health to post earnings ...

5. • 

     More people exposed to Manhattan Project chemicals deserve compensation, advocates say

     Fox News· 3 days ago

     The Radiation Exposure Compensation Act has been a lifeline for some people and families exposed to...

6. • Rakuten Securities Inc. Makes New Investment in Johnson & Johnson (NYSE:JNJ)

     ETF DAILY NEWS· 5 days ago

     Rakuten Securities Inc. bought a new stake in shares of Johnson & Johnson (NYSE:JNJ – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange ...

7. • Calamos Wealth Management LLC Has $4.82 Million Holdings in Johnson & Johnson (NYSE:JNJ)

     ETF DAILY NEWS· 2 days ago

     Calamos Wealth Management LLC raised its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 50.2% in the fourth quarter, according to its most recent 13F filing with the Securities ...

8. • Alvotech Announces Topline Results from a Confirmatory Clinical Study for AVT05, a Proposed...

     Benzinga· 4 days ago

     The confirmatory clinical safety and efficacy study for AVT05, biosimilar candidate to Simponi® and Simponi Aria® (golimumab), met its primary endpoint in patients with moderate to severe rheumatoid

9. • Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against...

     Morningstar· 7 days ago

     Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Ventyx Biosciences, Inc ...

10. • Bristol-Myers Squibb (NYSE:BMY) Forecasted to Post Q3 2024 Earnings of $1.67 Per Share

      ETF DAILY NEWS· 2 days ago

      Bristol-Myers Squibb (NYSE:BMY – Free Report) – Analysts at Zacks Research cut their Q3 2024 earnings per share (EPS) estimates for Bristol-Myers Squibb in a note issued to investors on Tuesday ...